说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 句库 -> 年龄别生存率
1.
TWO SEX AGE SPECIFIC SURVIVAL RATES AND THEIR DIFFERENCE AT OLDER AGES IN CHINA;
中国高老龄人口两性年龄别生存率及其差异变化
2.
age-marital duration specific fertility rate
年龄婚龄龄别生育率
3.
sex age specific death rate
分性别年龄的死亡率
4.
10-year survival rate and 10-year NED rate were 62.4% and 60.2%.
10年生存率、健在率分别为62.4%及60.2%。
5.
The 3-year overall survival (OS) and disease free survival ( DFS) was 66. 3% and 59. 5% , respectively.
3年总生存率和无病生存率分别为66.3%和59.5%。
6.
The five-year survival rate (SR),disease free survival rate (DFSR) were 65 6% and 54 5%,respectively.
总的5年生存率、无瘤生存率分别为65.6%和54.5%。
7.
The 5 -year overall survival (OS) and disease free survival (DFS) were 89% and 73%,respectively.
全组5年总生存率和无病生存率分别为89%和73%。
8.
A Composite Age-Specific Fertility Rate Model Based on Random Distribution Functions;
基于随机分布函数的分年龄别生育率组合模型
9.
However,there is no significant difference between the age and sex,or calendar age and bone age.
而在年龄、性别之间,以及生日年龄和骨骼年龄之间不存在显著性差异。
10.
The 1, 3 and 5-year sur-vival rate were 40.8%.
全组1、3、5年生存率分别为40.80%、16.11%、11.39%;
11.
Examining of and Discussion about Exceptional Death Rate by Age;
年龄别死亡率数据异常的检验与讨论
12.
Study on the correlation between corneal curvature and age,sexual
角膜曲率与年龄及性别的相关性分析
13.
The 1-,3- and 5-year survivals for the preoperative group were 72.77%, 62.78%and 48.30%respectively.
治疗性栓塞组1、3年生存率分别为41.18%和26.48%。
14.
The 5-year survival rate of benign PRT was 89.29%, the 5-year survival rate of malignant PRT was 20.80%.
良、恶性肿瘤5年生存率分别为89·29%和20·80%。
15.
After fie years, the oerall surial in the three groups was 17%, 28% and 34%, respectiely.
五年随访,三个组的生存率分别为17%,28%和34%。
16.
Results After treatment, the1_、2_ year_ survival rates were42.1%、31.6% respectively, median survival time10.5 months.
结果治疗后1、年生存率分别为421%316%,中位生存期105个月。
17.
"fertility rate: Births per thousand, usually related to individuals of same sex, age, marital status, etc."
生育率:每千人平均生育率,通常以相同性别、年龄和婚姻状况的人为基
18.
The DFS and probability of relapse at 5 years were 6 7.8%and 16.8%respectively for all patients.
全组患者5年无病生存率及复发率分别为67.8%及16.8%。